Henri Kagan and Kenso Soai Share 2026 Nobel Prize in Chemistry for Unlocking Homochirality Mystery

Henri Kagan and Kenso Soai won the 2026 Nobel Prize in Chemistry for resolving the century-old mystery of homochirality, advancing molecular science and drug design.

Breaking

Topics:
Image: svt.se

Key details

  • Henri B. Kagan and Kenso Soai awarded the 2026 Nobel Prize in Chemistry for research on chemical asymmetry and homochirality.
  • Their discoveries explain why biological molecules are predominantly one mirror-image form, solving a chemical mystery over 100 years old.
  • Kagan developed methods in 1986 to produce skewed mirror image molecule ratios; Soai created the first homochiral reaction in 1995 and achieved pure single mirror image synthesis by 2003.
  • Their research has direct pharmaceutical applications, improving drug safety and effectiveness, as exemplified by historical drug safety issues like the Neurosedyn scandal.

Henri B. Kagan from France and Kenso Soai from Japan have been jointly awarded the 2026 Nobel Prize in Chemistry for their pioneering research on chemical asymmetry and homochirality, a phenomenon crucial to the molecular basis of life and pharmaceutical development. Their work provides vital insights into why molecules in living organisms exist predominantly in one mirror-image form rather than as equal mixtures, solving a century-old scientific puzzle.

Homochirality refers to the preference for one of two mirror-image forms of a molecule, with significant implications in biology and medicine. As the chair of the Nobel Committee for Chemistry, Heiner Linke, explained, Kagan and Soai have "solved a chemical conundrum that has puzzled scientists for over a century" by demonstrating how non-linear effects and autocatalysis in asymmetric organic synthesis facilitate the spontaneous emergence of homochirality.

Kagan’s breakthrough in 1986 introduced methods to manipulate chemical reactions to produce a greater excess of one molecular mirror image. Building on this, Soai designed the first chemical reaction capable of achieving homochirality in 1995 and successfully created a reaction that yielded only one mirror image by 2003. Their work enables chemists to drive reactions toward producing molecules of a single handedness, a capability vital for drug manufacturing.

The importance of homochirality in medicine is underscored by historical examples such as the Neurosedyn tragedy of the 1960s, where the presence of the incorrect mirror image of a drug caused thousands of birth defects. According to Sara Linse of the Royal Swedish Academy of Sciences, Kagan and Soai’s discoveries are already applied in the production of asthma medications and antiviral agents, illustrating tangible benefits for pharmaceutical innovation.

Ellen Moons, permanent secretary of the Nobel Committee, emphasized that the laureates’ groundbreaking research not only solves a fundamental chemical mystery but also paves the way for advanced drug development and improved pharmaceutical safety and efficacy. This recognition celebrates work that bridges fundamental science with critical practical applications that impact health worldwide.

This article was translated and synthesized from Swedish sources, providing English-speaking readers with local perspectives.

Source articles (3)

  1. svt.se Oct 7, 2026

    Henri Kagan och Kenso Soai delar på årets Nobelpris i kemi

  2. feber.se Oct 7, 2026

    Två får dela på Nobelpriset i kemi. För forskning om kemisk asymmetri.

  3. epochtimes.se Oct 7, 2026

    Nobelpris för lösning på 100-årig kemisk gåta

Source comparison

The key details of this story are consistent across the source articles

Latest news

The top news stories in Sweden

Delivered straight to your inbox each morning.